13 studies found for:    appendiceal cancer | Open Studies
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Not yet recruiting Gastrointestinal Microbiome Study of Appendiceal Cancer
Conditions: Pseudomyxoma Peritonei;   Appendiceal Neoplasm;   Cancer, Appendiceal
Interventions: Other: Bio-specimen collection;   Other: Questionnaire
2 Recruiting Trial of Intraperitoneal (IP) Oxaliplatin in Combination With Intravenous FOLFIRI
Conditions: Colorectal Cancer;   Appendix Cancer;   Peritoneal Carcinomatosis
Intervention: Drug: Oxaliplatin
3 Recruiting Crossover Trial of Systemic Chemotherapy in Patients With Metastatic Well-differentiated Mucinous Appendiceal Adenocarcinomas With Pseudomyxoma Peritonea
Condition: Gastrointestinal Neoplasms
Intervention: Behavioral: Questionnaire
4 Recruiting ICARuS Post-operative Intraperitoneal Chemotherapy (EPIC) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) After Optimal Cytoreductive Surgery (CRS) for Neoplasms of the Appendix, Colon or Rectum With Isolated Peritoneal Metastasis
Conditions: Appendix Cancer;   Colorectal Cancer
Interventions: Procedure: Cytoreductive Surgery;   Drug: HIPEC with Mitomycin-C;   Drug: EPIC with FUDR and Leucovorin
5 Recruiting Antibiotic Treatment and Long-term Outcomes of Patients With Pseudomyxoma Peritonei of Appendiceal Origin
Conditions: Pseudomyxoma Peritonei;   Appendiceal Neoplasms
Intervention: Drug: PrevPac (Prevacid, Amoxicillin, Clarithromycin)
6 Recruiting Postoperative Chemotherapy in High-Grade Appendiceal Adenocarcinoma With Peritoneal Carcinomatosis
Condition: Cancer
Intervention: Drug: systemic chemotherapy
7 Recruiting The Comparison of Outcomes of Antibiotic Drugs and Appendectomy (CODA) Trial
Condition: Appendicitis
Interventions: Drug: Cefoxitin, Ertapenem, Moxifloxacin, Tigecycline, Ticarcillin-Clavulanic Acid; Metronidazole plus Cefazolin, Cefuroxime, Ceftriaxone, Cefotaxime, Ciprofloxacin, or Levofloxacin;   Procedure: Appendectomy
8 Recruiting Safety and Effect of GL-ONC1 Administered IV With or Without Eculizumab Prior to Surgery to Patients With Solid Organ Cancers Undergoing Surgery
Condition: Solid Organ Cancers
Interventions: Biological: GL-ONC1;   Biological: Eculizumab
9 Recruiting Biweekly Intraperitoneal Oxaliplatin With Systemic Capecitabine and Bevacizumab for Patients With Peritoneal Carcinomatosis From Appendiceal or Colorectal Cancer
Condition: Carcinoma
Interventions: Drug: Intraperitoneal Oxaliplatin;   Drug: Bevacizumab;   Drug: Capecitabine
10 Recruiting Phase I/IIA Study MK-3475 With Chemotherapy in Patients With Advanced GI Cancers
Condition: Advanced GI Cancer
Intervention: Drug: MK-3475
11 Recruiting Cytoreduction Followed by Normothermic Versus Hyperthermic Intraperitoneal Intraoperative Chemoperfusion (HIPEC): a Study in Peritoneal Carcinomatosis
Condition: Peritoneal Carcinomatosis
Interventions: Procedure: Hyperthermic intraoperative Peritoneal Chemoperfusion;   Drug: Hyperthermic intraoperative Peritoneal Chemoperfusion
12 Recruiting Community-based Neuroendocrine Tumor (NET) Research Study
Condition: Gastroenteropancreatic Neuroendocrine Tumors
Intervention:
13 Unknown  Optimizing Influenza Vaccination in Surgical Oncology Patients
Condition: Influenza
Intervention: Biological: Influenza vaccine

Indicates status has not been verified in more than two years